Original article
Morbidity in asthma in relation to the menstrual cycle

https://doi.org/10.1016/0091-6749(86)90328-3Get rights and content

Abstract

After observing three cases of severe recurrent exacerbations of asthma in relation to menstruation, we conducted a survey among women with asthma inquiring about the relationship of asthma symptoms to the menstrual cycle. Of 57 women with asthma, 19 (33%) had significant worsening (p = 0.006) of total pulmonary symptom scores during either the premenstrual period, the menstrual period, or both with maximum increase in dyspnea, wheezing, and chest tightness during the premenstrual period (p = 0.002). The other 38 (66%) women noted no such changes in their asthma. Logistic regression analysis comparing women with and without worsening of their asthma around menstruation revealed that the former group reported significantly more severe wheezing in general (p < 0.05) and also more severe pulmonary symptoms during the premenstrual period (p < 0.05). Of the women whose asthma was affected by menses, 13 (68%) had been hospitalized for asthma but only 10 (26%) of the women who were unaffected (p = 0.002). Both dysmenorrhea scores and premenstrual syndrome scores correlated significantly with baseline pulmonary symptom scores in the premenstrual asthma group. It appears that asthma morbidity is affected by the menstrual cycle in a subgroup of women with asthma.

References (27)

  • BG Ferris

    Epidemiology standardization project. American Thoracic Society

    Am Rev Respir Dis

    (1978)
  • PW Budoff

    Zomepirac sodium in the treatment of primary dysmenorrhea syndrome

    N Engl J Med

    (1982)
  • C Wood

    The treatment of premenstrual symptoms with mefenamic acid

    Br J Obstet Gynaecol

    (1980)
  • Cited by (158)

    • The Role of Comorbidities in Difficult-to-Control Asthma in Adults and Children

      2022, Journal of Allergy and Clinical Immunology: In Practice
      Citation Excerpt :

      Scant evidence exists for the use of a phosphodiesterase inhibitor, such as roflumilast.194 Approximately one-third of reproductive age women experience changes of ovarian hormones during the menstrual cycle that have been linked to increased symptoms and decreased peak flow rates,195,196 correlating with increased sputum eosinophils and FeNO during the premenstrual phase.197 Women with perimenstrual worsening of asthma also report greater urgent health care utilization for asthma,198 though ED-based studies have not found variation in menstrual phase among women presenting with asthma exacerbations.199,200

    • Sex, Cells, and Asthma

      2021, Mayo Clinic Proceedings
    • Hormones, sex, and asthma

      2018, Annals of Allergy, Asthma and Immunology
    • Asthma and gender: The female lung

      2017, Pharmacological Research
    View all citing articles on Scopus

    Supported by a grant from the University of Connecticut Research Foundation.

    View full text